Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Voltz, Emilie
7  Ergebnisse:
Personensuche X
?
1

First‐in‐human safety, tolerability, and pharmacokinetic re..:

Gatlik, Ewa ; Mehes, Beata ; Voltz, Emilie...
Clinical and Translational Science.  17 (2024)  5 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
2

Intravenous Dosing as an Alternate Approach to Safely Achie..:

Ufer, Mike ; Sagkriotis, Alexandros ; Salunke, Atish...
Clinical Therapeutics.  38 (2016)  12 - p. 2589-2597 , 2016
Link: https://doi.org/10.1016/..
 
?
3

A new era of cancer therapy: Cancer cell targeted therapies..:

Voltz, Emilie ; Gronemeyer, Hinrich
The International Journal of Biochemistry & Cell Biology.  40 (2008)  1 - p. 1-8 , 2008
Link: https://doi.org/10.1016/..
 
?
4

Tumor-selective action of HDAC inhibitors involves TRAIL in..:

Nebbioso, Angela ; Clarke, Nicole ; Voltz, Emilie...
Nature Medicine.  11 (2004)  1 - p. 77-84 , 2004
Link: https://doi.org/10.1038/..
 
?
5

Tumor suppressor IRF-1 mediates retinoid and interferon ant..:

Clarke, Nicole ; Jimenez-Lara, Ana M ; Voltz, Emilie.
The EMBO Journal.  23 (2004)  15 - p. 3051-3060 , 2004
Link: https://doi.org/10.1038/..
 
?
6

90 Regulation of cell life and death by retinoids:

Gronemeyer, Hinrich ; Altucci, Lucia ; Clarke, Nicole...
Toxicology Letters.  144 (2003)  - p. s27 , 2003
Link: https://doi.org/10.1016/..
 
?
7

Tumor suppressor IRF-1 mediates retinoid and interferon ant..:

Clarke, Nicole ; Jimenez-Lara, Ana M ; Voltz, Emilie.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC514919.  , 2004
Link: http://www.ncbi.nlm.nih...
 
1-7